Kenneth T. Sim
CIK 1725499 · View on SEC EDGAR ↗
Insider
First SEC filing: March 29, 2018 · Latest: March 29, 2018
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 41 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
41 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 14, 2020 | ASTH | P | 5,000 | $17.23 | $86,150 | 42,996 Indirect | +13.16% | Acquired | 138.0% (price as of 2026-08-19) |
| Sept. 14, 2020 | ASTH | P | 1,000 | $17.20 | $17,200 | 17,379 Indirect | +6.11% | Acquired | 138.4% (price as of 2026-08-19) |
| Sept. 10, 2020 | ASTH | P | 5,000 | $17.60 | $88,000 | 37,996 Indirect | +15.15% | Acquired | 133.0% (price as of 2026-08-19) |
| Sept. 9, 2020 | ASTH | P | 5,000 | $17.60 | $88,000 | 37,996 Indirect | +15.15% | Acquired | 133.0% (price as of 2026-08-19) |
| Aug. 27, 2020 | ASTH | P | 5,000 | $18.34 | $91,700 | 1,770,556 Indirect | +0.28% | Acquired | 123.6% (price as of 2026-08-19) |
| Nov. 14, 2019 | ASTH | P | 10,000 | $14.67 | $146,700 | 1,737,561 Indirect | +0.58% | Acquired | 179.5% (price as of 2026-08-19) |
| Oct. 8, 2019 | ASTH | P | 5,000 | $15.55 | $77,750 | 1,727,561 Indirect | +0.29% | Acquired | 163.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 10, 2025 | ASTH | Stock Option (right to buy) | Common Stock (29,502) | $17.78 | Dec. 10, 2025 | 29,502 | Disposed |
| Nov. 18, 2024 | ASTH | Stock option (right to buy) | Common Stock (28,046) | $18.65 | Dec. 30, 2024 | 28,046 | Disposed |
| Dec. 8, 2022 | ASTH | Warrants to purchase Common Stock | Common Stock (51,445) | $10.00 | Dec. 8, 2022 | 51,445 | Disposed |
| Dec. 8, 2022 | ASTH | Warrants to purchase Common Stock | Common Stock (48,587) | $11.00 | Dec. 8, 2022 | 48,587 | Disposed |
| March 30, 2021 | ASTH | Warrant to Purchase Common Stock | Common Stock (31,756) | $10.00 | March 30, 2021 | 31,756 | Disposed |
| Dec. 10, 2020 | ASTH | Stock Option (right to buy) | Common Stock (29,502) | $17.78 | Dec. 10, 2025 | 29,502 | Acquired |
| Sept. 8, 2020 | ASTH | Warrants to Purchase Common Stock | Common Stock (63,512) | $9.00 | Oct. 14, 2020 | 63,512 | Disposed |
| Dec. 30, 2019 | ASTH | Stock Option (right to buy) | Common Stock (28,046) | — | Dec. 30, 2024 | 28,046 | Acquired |
| Dec. 27, 2019 | ASTH | Stock Option (right to buy) | Common Stock (39,189) | — | Sept. 30, 2024 | 39,189 | Disposed |
| Sept. 30, 2019 | ASTH | Stock Option (right to buy) | Common Stock (39,189) | — | Sept. 30, 2024 | 39,189 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 29, 2018 | ASTH | Common Stock [F1,F2] | 1,563,804 | Direct |
| March 29, 2018 | ASTH | Common Stock [F3,F4] | 1,682,109 | Indirect |
| Dec. 18, 2017 | ASTH | Common Stock [F1,F2] | 1,547,019 | Direct |
| Dec. 18, 2017 | ASTH | Common Stock [F3,F6] | 1,664,054 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F4]→ Common Stock (63,513) | 63,513 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F4]→ Common Stock (31,756) | 31,756 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F2]→ Common Stock (51,445) | 51,445 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F2]→ Common Stock (48,587) | 48,587 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F5]→ Common Stock (68,317) | 68,317 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F5]→ Common Stock (34,159) | 34,159 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F6]→ Common Stock (55,337) | 55,337 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F6]→ Common Stock (52,263) | 52,263 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ASTH
M.D. Executive Chairman| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $950,000 | $100,000 | — | — | — | — | $24,170 | $1,074,170 |
| 2024 | $950,000 | — | $9,392,000 | — | — | — | $20,866 | $10,362,866 |
| 2022 | $950,000 | $450,000 | — | — | — | — | $94,015 | $1,494,015 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.